As of 2025-05-18, the EV/EBITDA ratio of Silo Pharma Inc (SILO) is 0.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SILO's latest enterprise value is -1.74 mil USD. SILO's TTM EBITDA according to its financial statements is -4.69 mil USD. Dividing these 2 quantities gives us the above SILO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.5x - 9.4x | 6.4x |
| Forward P/E multiples | 3.1x - 9.1x | 6.1x |
| Fair Price | (2.77) - (8.66) | (5.70) |
| Upside | -673.9% - -1892.1% | -1279.8% |
| Date | EV/EBITDA |
| 2025-05-14 | 0.03 |
| 2025-05-13 | -0.22 |
| 2025-05-12 | -0.19 |
| 2025-05-09 | 0.05 |
| 2025-05-08 | 0.05 |
| 2025-05-07 | 0.06 |
| 2025-05-06 | 0.05 |
| 2025-05-05 | 0.12 |
| 2025-05-02 | 0.12 |
| 2025-05-01 | 0.09 |
| 2025-04-30 | 0.12 |
| 2025-04-29 | 0.06 |
| 2025-04-28 | 0.03 |
| 2025-04-25 | -0.27 |
| 2025-04-24 | -0.26 |
| 2025-04-23 | -0.28 |
| 2025-04-22 | -0.24 |
| 2025-04-21 | -0.18 |
| 2025-04-17 | -0.19 |
| 2025-04-16 | -0.15 |
| 2025-04-15 | -0.17 |
| 2025-04-14 | -0.16 |
| 2025-04-11 | -0.18 |
| 2025-04-10 | -0.16 |
| 2025-04-09 | -0.20 |
| 2025-04-08 | -0.11 |
| 2025-04-07 | -0.14 |
| 2025-04-04 | -0.20 |
| 2025-04-03 | -0.22 |
| 2025-04-02 | -0.20 |
| 2025-04-01 | -0.25 |
| 2025-03-31 | -0.28 |
| 2025-03-28 | -0.36 |
| 2025-03-27 | -0.43 |
| 2025-03-26 | -0.47 |
| 2025-03-25 | -0.45 |
| 2025-03-24 | -0.48 |
| 2025-03-21 | -0.49 |
| 2025-03-20 | -0.48 |
| 2025-03-19 | -0.49 |
| 2025-03-18 | -0.49 |
| 2025-03-17 | -0.49 |
| 2025-03-14 | -0.49 |
| 2025-03-13 | -0.43 |
| 2025-03-12 | -0.41 |
| 2025-03-11 | -0.39 |
| 2025-03-10 | -0.35 |
| 2025-03-07 | -0.41 |
| 2025-03-06 | -0.42 |
| 2025-03-05 | -0.38 |